ScholarIQanswers from OpenAlex

A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer

PaperCitations, authors & open-access status

A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer is a paper indexed in ScholarIQ from OpenAlex.

How many citations does A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer have?

ScholarIQcitation count

A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer has 6,385 citations in the OpenAlex counts ScholarIQ stores.

When was A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer published?

ScholarIQyear

A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer has 2004 year in the ScholarIQ index.

What is the open-access status of A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer?

ScholarIQoa status

A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer has bronze oa status in the ScholarIQ index.

What is the DOI of A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer?

ScholarIQdoi

The DOI for A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer is on the source record.

What is the PMID of A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer?

ScholarIQpmid

The PMID for A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer is on the source record.

What is the OpenAlex record for A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer?

ScholarIQopenalex

The OpenAlex for A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial